Genome-wide admixture and association study of subclinical atherosclerosis in the Women’s Interagency HIV Study (WIHS) by Shendre, Aditi et al.
RESEARCH ARTICLE
Genome-wide admixture and association
study of subclinical atherosclerosis in the
Women’s Interagency HIV Study (WIHS)
Aditi Shendre1¤a, Howard W. Wiener1, Marguerite R. Irvin1, Bradley E. Aouizerat2,3, Edgar
T. Overton4, Jason Lazar5, Chenglong Liu6, Howard N. Hodis7, Nita A. Limdi8, Kathleen
M. Weber9, Stephen J. Gange10, Degui Zhi11¤b, Michelle A. Floris-Moore12,
Ighovwerha Ofotokun13, Qibin Qi14, David B. Hanna14, Robert C. Kaplan14,
Sadeep Shrestha1*
1 Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States
of America, 2 Bluestone Center for Clinical Research, New York University, New York, New York, United
States of America, 3 Department of Oral and Maxillofacial Surgery, New York University, New York, New
York, United States of America, 4 Division of Infectious Diseases, Department of Medicine, University of
Alabama at Birmingham, Birmingham, Alabama, United States of America, 5 Department of Medicine,
State University of New York, Downstate Medical Center, Brooklyn, New York, United States of America,
6 Department of Medicine, Georgetown University Medical Center, Washington, DC, United States of
America, 7 Atherosclerosis Research Unit, University of Southern California, Los Angeles, California, United
States of America, 8 Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama,
United States of America, 9 Cook County Health and Hospital System/Hektoen Institute of Medicine,
Chicago, Illnois, United States of America, 10 Department of Epidemiology, Johns Hopkins Bloomberg
School of Public Health, Baltimore, Maryland, United States of America, 11 Department of Biostatistics,
University of Alabama at Birmingham, Birmingham, Alabama, United States of America, 12 Division of
Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill,
North Carolina, United States of America, 13 Department of Medicine/Infectious Diseases, Emory University,
and Grady Healthcare System, Atlanta, Georgia, United States of America, 14 Department of Epidemiology
and Population Health, Albert Einstein College of Medicine, Bronx, New York, United States of America
¤a Current address: Richard M. Fairbanks School of Public Health, Indianapolis University–Purdue
University Indianapolis, Indianapolis, Indiana, United States of America
¤b Current address: School of Biomedical Informatics, The University of Texas Health Science Center at
Houston, Houston, Texas, United States of America
* sshrestha@uab.edu
Abstract
Cardiovascular disease (CVD) is a major comorbidity among HIV-infected individuals.
Common carotid artery intima-media thickness (cCIMT) is a valid and reliable subclinical
measure of atherosclerosis and is known to predict CVD. We performed genome-wide asso-
ciation (GWA) and admixture analysis among 682 HIV-positive and 288 HIV-negative
Black, non-Hispanic women from the Women’s Interagency HIV study (WIHS) cohort using
a combined and stratified analysis approach. We found some suggestive associations but
none of the SNPs reached genome-wide statistical significance in our GWAS analysis. The
top GWAS SNPs were rs2280828 in the region intergenic to mediator complex subunit 30
and exostosin glycosyltransferase 1 (MED30 | EXT1) among all women, rs2907092 in the
catenin delta 2 (CTNND2) gene among HIV-positive women, and rs7529733 in the region
intergenic to family with sequence similarity 5, member C and regulator of G-protein signal-
ing 18 (FAM5C | RGS18) genes among HIV-negative women. The most significant local
European ancestry associations were in the region intergenic to the zinc finger and SCAN
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history of substance use, commonly HCV-
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manuscript provided consent for genetic studies,
said consent was collected prior to the most recent
guidelines and requirements for data sharing.
Accordingly, the cohort is currently being re-
domain containing 5D gene and NADH: ubiquinone oxidoreductase complex assembly fac-
tor 1 (ZSCAN5D | NDUF1) pseudogene on chromosome 19 among all women, in the region
intergenic to vomeronasal 1 receptor 6 pseudogene and zinc finger protein 845 (VN1R6P |
ZNF845) gene on chromosome 19 among HIV-positive women, and in the region intergenic
to the SEC23-interacting protein and phosphatidic acid phosphatase type 2 domain contain-
ing 1A (SEC23IP | PPAPDC1A) genes located on chromosome 10 among HIV-negative
women. A number of previously identified SNP associations with cCIMT were also observed
and included rs2572204 in the ryanodine receptor 3 (RYR3) and an admixture region in the
secretion-regulating guanine nucleotide exchange factor (SERGEF) gene. We report sev-
eral SNPs and gene regions in the GWAS and admixture analysis, some of which are com-
mon across HIV-positive and HIV-negative women as demonstrated using meta-analysis,
and also across the two analytic approaches (i.e., GWA and admixture). These findings sug-
gest that local European ancestry plays an important role in genetic associations of cCIMT
among black women from WIHS along with other environmental factors that are related to
CVD and may also be triggered by HIV. These findings warrant confirmation in independent
samples.
Introduction
Early diagnosis and treatment of human immunodeficiency virus (HIV) has increased the life
expectancy of infected individuals [1], and shifted the focus to the management of other
comorbidities such as cardiovascular disease (CVD). CVD risk is higher among HIV-positive
individuals compared to HIV-negative individuals [2–4]. HIV infection as well as certain
antiretroviral therapies (ART) were shown to independently increase the risk of CVD [2].
Moreover, disparities in CVD risk by race and sex prevail, specifically, among HIV-positive
individuals [5, 6]. Higher rates of acute myocardial infarction were observed among Blacks as
compared to Whites, and among women as compared to men [3–5]. Similarly, ischemic stroke
rates were reported to be higher among HIV-positive women as compared to HIV-positive
men [7].
Efforts to prevent CVD among HIV-positive individuals have led to the evaluation of sub-
clinical atherosclerotic measures such as carotid artery intima-media thickness (CIMT). CIMT
can predict future CVD events among HIV-negative individuals [8]. CIMT is a non-invasive
measure obtained using B-mode ultrasound, with the common carotid artery measurements
considered the most reliable and reproducible of all CIMT segments [9, 10]. Common CIMT
(cCIMT) measurements were reported to be thicker among HIV-positive as compared to
matched HIV-negative individuals, and also independently associated with HIV infection and
treatment [11, 12]. Racial and sex differences have shown greater cCIMT thickness among
Blacks as compared to Whites, and among women as compared to men beyond traditional
CVD risk factors [13–15].
The role of genetics as a risk factor for subclinical atherosclerosis, specifically in genome-
wide association studies (GWAS) of cCIMT, has been explored among the HIV-negative [16]
and non-Black populations [16–18]. A recent study on subclinical atherosclerosis that con-
ducted a exome-wide association analysis, reported two SNPs–rs7412 in the apolipoprotein E
(APOE) gene and rs143873045 in the KN Motif and Ankyrin Repeat Domains 2 (KANK2)
gene that were found significantly associated with cCIMT among HIV-negative Blacks [19].
Among HIV-positive individuals, the only GWAS in relation to cCIMT has been conducted
GWAS and admixture mapping of cIMT among HIV in WIHS
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and Human Development (NICHD), the National
Cancer Institute (NCI), the National Institute on
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The cardiovascular substudies in WIHS are also
supported by 1R01HL126543, 1R21HL120394,
1R01HL083760, 1R01HL095140. The analysis in
this study was supported by the pilot project funds
by our group, among White men from the Fat Redistribution and Metabolic Change in HIV
Infection (FRAM) Study [20]. We observed two single nucleotide polymorphisms (SNPs) in
tight linkage disequilibrium (LD), rs2229116 and rs7177922, in the ryanodine receptor 3
(RYR3) gene on chromosome 15 to be associated with cCIMT. The association of rs2229116
was replicated in another group of HIV-positive White men from the Multicenter AIDS
Cohort Study (MACS) [21]. Given the consistent association with cCIMT in HIV-positive
White men, we further evaluated the association of SNPs within the RYR3 gene among a
racially diverse group of HIV-positive women from the Women’s Interagency HIV Study
(WIHS) [22]. The RYR3 gene association with cCIMT was observed among different SNPs
than those reported earlier, rs2572204 being most significant among Black HIV-positive
women. Haplotype blocks observed among the Black HIV-positive women compared to the
other two racial/ethnic groups were smaller and indicated that SNP associations are possibly
different based on LD, warranting further evaluation specifically in the context of cCIMT
related admixture.
Admixture mapping enables the identification of genetic variations differentially distrib-
uted in ancestral populations associated with a disease–the premise being that associated
variants are observed on chromosomal segments from ancestral populations with higher prev-
alence of the disease/trait [23]. Thus, this approach takes advantage of the extended LD present
in the recently admixed population to discover these variations. Admixture mapping has been
considered a feasible and more powerful tool in contrast to GWAS among individuals of
mixed continental ancestry [24], and advances in statistical techniques and their applications
in a genome-wide set of markers has greatly increased the ability to detect disease loci. We
recently performed genome-wide admixture mapping in relation to cCIMT among HIV-nega-
tive Black individuals from two large prospective cohorts and found a region in the secretion
regulating guanine nucleotide exchange factor (SERGEF) gene that reached genome-wide sig-
nificance [25]. Likewise, we have shown various genomic regions associated with clinical
events in African Americans through admixture mapping [26].
Currently, methods based on principal components are commonly used to control for pop-
ulation stratification in genetic association studies [27]. Recent studies have focused on admix-
ture mapping and related techniques to incorporate ancestry information in association tests
among admixed populations [28–32]. However, there is a lack of consensus in approaches and
whether accounting for local and global ancestries alone or together would sufficiently control
for both type I and type II error rates [31, 32]. In this study, we performed genome-wide
admixture and association analysis to determine single SNP and local European ancestry asso-
ciations with cCIMT among Black women from the WIHS cohort.
Results
The HIV and CVD related characteristics of the 970 Black women included in the current
study are presented in Table 1. In this study, 70% of the women were HIV-positive, and had
similar cCIMT values as well as percent global European ancestry as compared to HIV-nega-
tive women. CVD risk factors including hypertension, diabetes, and current smoking were
similar across the two groups. HIV-positive women were older, had lower CD4 cell count and
HDL cholesterol levels, and were more likely to take medications for hypertension compared
to HIV-negative women.
Genome-wide association results
The genome-wide association results for cCIMT are presented for all women and after further
stratification by HIV status, as shown in the Manhattan plots (Fig 1A–1C). None of the SNPs
GWAS and admixture mapping of cIMT among HIV in WIHS
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reached the genome-wide significance level (S1 Table), but we present the top 5 SNP-cCIMT
associations for all three groups (Table 2) and the regionals plots for the top SNPs in each
group (S1A–S1C Fig). The lambda values for each of the GWAS models were– 1.005 for the
combined model, 1.009 for the HIV-positive model, and 1.013 for the HIV-negative model
(Fig 2A–2C). We also present the admixture analyses results for gene regions that include
these significant GWAS SNPs to determine if local European ancestry at these regions is asso-
ciated with cCIMT in Table 2. The top hit among all women was rs2280828 located in the
intergenic region of mediator complex subunit 30 and exostosin glycosyltransferase 1 (MED30
| EXT1) genes on chromosome 8 (β = -0.0216, p = 8.01x10-7). The same SNP was also signifi-
cantly associated with cCIMT among HIV-positive women (β = -0.0271, p = 2.89x10-7). The
most significant SNP associated with cCIMT among HIV-positive women was rs2907092 in
the catenin delta 2 (CTNND2) gene on chromosome 5 (β = 0.0250, p = 2.37x10-7). Local Euro-
pean ancestry at the corresponding gene region of this SNP was also associated with cCIMT
(β = 0.0089, p = 0.04). Local European ancestry was also associated with cCIMT at the gene
region that includes the GWAS identified rs4761669 intergenic to the transmembrane and
coiled-coil domain family 3 gene and the NADH: ubiquinone oxidoreductase subunit A12
(TMCC3 | NDUFA12) genes on chromosome 12 (β = -0.0084, p = 0.04). Among HIV-negative
women, rs7529733 intergenic to family with sequence similarity 5, member C and regulator of
G-protein signaling 18 genes (FAM5C | RGS18) on chromosome 1 was the top SNP associated
with cCIMT (β = 0.0431, p = 2.92x10-7).
Local ancestry association results
The local European ancestry (LEA) association with cCIMT is presented in Table 3 for the top
5 gene regions for all women and then separately for HIV-positive and HIV-negative women,
and the corresponding Manhattan plots are presented in Fig 1D–1F. The regionals plots for
the top regions are presented in S1D–S1F Fig (all regions in S2 Table). The lambda values for
each of the admixture models were– 1.001 for the combined model, 1.103 for the HIV-positive
model, and 1.000 for the HIV-negative model (Fig 2D–2F). We also present the top GWAS hit
located within the top ancestry gene regions if it was significant at α of 0.05 (Table 3). LEA at
17 gene regions reached genome-wide significance in relation to cCIMT among all women.
These regions were largely located on chromosome 19 over a 3.07 Mb region but also included
Table 1. Characteristics of all women from the Women’s Interagency HIV Study (WIHS) cohort and by HIV status.
Characteristics All (N = 970) HIV positive (N = 682) HIV negative (N = 288)
cCIMT (mm), mean (SD) 0.74 (0.12) 0.75 (0.12) 0.74 (0.12)
Percent global European ancestry, mean (SD) 15.7 (8.5) 15.7 (8.4) 15.7 (8.6)
Age (years), mean (SD) 41.1 (9.3) 41.9 (8.8) ** 39.1 (10.0)
CD4 cell count (cells/mm3), median (IQR) 577 (559) 436 (393) ** 1029 (516)
Anti-retroviral therapy, n (%) - 633 (92.3) -
Hypertension, n (%) 343 (35.4) 250 (36.7) 93 (32.3)
Diabetes, n (%) 135 (13.9) 93 (13.6) 42 (14.6)
Current smoking, n (%) 504 (51.9) 352 (51.6) 152 (52.8)
HDL cholesterol (mg/dL), mean (SD) 51.3 (18.1) 49.2 (18.2) ** 56.1 (16.7)
LDL cholesterol (mg/dL), mean (SD) 100.1 (33.7) 98.9 (33.1) 102.9 (35.0)
HIV: human immunodeficiency virus, SD: standard deviation, IQR: inter-quartile range, HDL: high density lipoprotein, LDL: low density lipoprotein
*P<0.01
**P<0.001
https://doi.org/10.1371/journal.pone.0188725.t001
GWAS and admixture mapping of cIMT among HIV in WIHS
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one gene region on chromosome 6 spanning 106.38 kb. There were no gene regions that re-
ached genome-wide significance among HIV-positive women. Among HIV-negative women,
a total of 48 LEA gene regions achieved genome-wide significance and were largely located on
chromosome 10 over a span of 4.23 Mb. A single gene region each on chromosomes 2, 4, and
9 also achieved genome-wide significance among HIV-negative women. The most significant
local European ancestry association among all women was observed in the region intergenic to
the zinc finger and SCAN domain containing 5D gene and NADH: ubiquinone oxidoreduc-
tase complex assembly factor 1 pseudogene (ZSCAN5D | NDUF1) on chromosome 19 (β =
0.0134, p = 8.87x10-5). The region on chromosome 6 in the leucine rich repeat containing 1
gene (LRRC1) achieved genome-wide significance among all women but was also observed
among the top 5 regions in HIV-positive women (β = 0.0138, p = 8.42x10-4). The region inter-
genic to the vomeronasal 1 receptor 6 pseudogene and zinc finger protein 845 gene (VN1R6P |
ZNF845) on chromosome 19 was most significant among HIV-positive women (β = 0.0141,
p = 6.86x10-4). Among HIV-negative women, the top association was observed in the region
intergenic to the SEC23 interacting protein gene and phosphatidic acid phosphatase type 2
domain containing 1A gene located on chromosome 10 (SEC23IP | PPAPDC1A) (β = -0.0290,
p = 1.71x10-5).
Meta-analysis and previously significant SNPs
Previously significant SNPs associated with cCIMT that were found significant in the current
GWAS and LEA association analysis are reported in the Tables 4 and 5, respectively. A total of
25 SNPs in the GWAS and 31 SNPs in the admixture analysis were significantly associated
with cCIMT. The most significant SNPs across the combined and stratified GWAS analyses
Fig 1. Manhattan plots for the genome-wide association (threshold p-value = 6.50×10−8) and
admixture analyses (threshold p-value 3.42×10−4). a) All women (GWAS), b) HIV-positive women
(GWAS), c) HIV-negative women (GWAS), d) All women (admixture), e) HIV-positive women (admixture),
and f) HIV-negative women (admixture). Negative log10 p-values are plotted against each SNP’s respective
position on each chromosome.
https://doi.org/10.1371/journal.pone.0188725.g001
GWAS and admixture mapping of cIMT among HIV in WIHS
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were—rs445925 in the apolipoprotein C-1 (APOC1) gene among all women (β = -0.0081,
p = 0.0018), rs2572204 in the ryanodine receptor 3 (RYR3) among HIV-positive women (β =
0.0153, p = 0.0027), and rs854571 in paraoxonase 1 (PON1) gene in the HIV-negative women
(β = 0.0107, p = 0.02). The most significant SNPs in the LEA association included rs1436023 in
LOC105375856gene in the combined analysis (β = -0.0099, p = 0.005), the region between
17.809 to 18.035 Mb in the SERGEF gene significantly associated with cCIMT among the HIV-
positive women (β = -0.0093, p = 0.02) whereas the SNP rs11120748 in the CD55 molecule
(Cromer blood groups) (CD55) gene was significant among HIV-positive women (β = -0.0156,
p = 0.02).
Meta-analysis results for both GWAS and LEA associations reflect the results observed in
the combined analyses (S1 and S2 Tables).
Discussion
The current study presents the genome-wide admixture and association findings for cCIMT
among Black HIV-positive and HIV-negative women from the WIHS cohort. We ran separate
analyses for the two methods but also noted whether any of the GWAS SNPs within the top
admixture regions, and any of the admixture regions including the top GWAS SNPs were sig-
nificant for cCIMT. We observed SNPs in the GWA that showed suggestive associations
(p<10−6) with cCIMT (included in Table 2 in bold). The comparison to the admixture results
yielded two significant regions observed among HIV-positive women (included in Table 2 in
bold). Conversely, several regions with LEA associations revealed GWAS SNPs that were nom-
inally significant. Meta-analysis results suggest that some SNPs and gene regions are common
Fig 2. QQ plots for the genome-wide association analyses and admixture analyses. a) All women
(GWAS, λ = 1.005), b) HIV-positive women (GWAS, λ = 1.009), c) HIV-negative women (GWAS, λ = 1.013),
d) All women (admixture, λ = 1.001), e) HIV-positive women (admixture, λ = 1.103), and f) HIV-negative
women (admixture, λ = 1.000). Observed negative log10 p-values are plotted against the expected negative
log10 p-values.
https://doi.org/10.1371/journal.pone.0188725.g002
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across HIV-positive and HIV-negative women and may therefore play a role in atherosclerosis
beyond HIV associated risk factors. Lastly, we observed associations with SNPs that have been
previously reported to have significant associations with cCIMT.
The top GWAS hit rs2280828 observed in the combined analysis was in the region inter-
genic to the MED30 and EXT1 genes on chromosome 8, approximately 50 kb from the EXT1
gene. The EXT1 gene encodes for a transmembrane glycoprotein on the endoplasmic reticu-
lum (ER) of the cell which is involved in the synthesis and polymerization of heparan sulfate
[33, 34]. Heterozygous loss of function mutation in the EXT1 and EXT2 genes have been pos-
tulated to improve endothelial function by increasing the bioavailability of nitric oxide (NO)
[35]. Calcium ion concentrations in the cell regulate the activity of nitric oxide synthase via cal-
modulin, indirectly influencing the release of nitric oxide when shear stress is exerted on the
endothelium [36]. The RYR3 receptor encoded by the RYR3 gene is a calcium-ion channel
Table 4. Genome wide association results (GWA) for common carotid artery intima media thickness
with previously significant single nucleotide polymorphisms (SNPs).
Chromosome Position SNP Minor
allele
Gene Location Beta P from
GWAS
Combined
19 45415640 rs445925 T APOC1 -0.0081 0.002
7 68047178 rs10248387 G LOC102723427,
LOC100507468
-0.0074 0.006
9 106487753 rs4436177 G LINC01492,
LOC101928523
0.0099 0.02
15 33795710 rs2572204 A RYR3 0.0098 0.02
7 94954619 rs854571 C PON1 0.0058 0.02
15 31421676 rs783026 G TRPM1 0.0057 0.02
5 149176945 rs1012543 C PPARGC1B 0.0083 0.03
18 8797189 rs566890 G MTCL1 -0.0051 0.03
2 239128117 rs6722019 T ILKAP, LOC151174 0.0051 0.04
13 106376128 rs1328070 T LINC00343 0.0074 0.04
6 135237158 rs6569979 G HBS1L 0.0049 0.04
HIV-positive
15 33795710 rs2572204 A RYR3 0.0153 0.003
7 68047178 rs10248387 G LOC102723427,
LOC100507468
-0.0095 0.004
9 106487753 rs4436177 G LINC01492,
LOC101928523
0.0139 0.005
19 45415640 rs445925 T APOC1 -0.0079 0.01
15 98680170 rs2871596 C LINC01582,
FAM169B
-0.0067 0.03
HIV-negative
7 94954619 rs854571 C PON1 0.0107 0.02
20 56157341 rs6025645 A PCK1 -0.0105 0.02
4 2906707 rs4961 T ADD1 0.0189 0.02
18 8797189 rs566890 G MTCL1 -0.0096 0.02
4 75683594 rs4352548 C BTC 0.0209 0.03
10 45917376 rs3780901 C ALOX5 0.0098 0.03
7 33701425 rs10246872 G BBS9, BMPER 0.0091 0.04
1 92076523 rs1041159 C CDC7, TGFBR3 -0.0088 0.04
5 13214852 rs28207 T LOC105374659,
RPS23P5
-0.0131 0.04
https://doi.org/10.1371/journal.pone.0188725.t004
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present on the ER and is involved in calcium homeostasis [37]. Thus, EXT1 may play a role in
atherosclerosis by regulating endothelial function in conjunction with RYR3. On the other
hand, the MED30 gene is part of a large group of genes that encode the mediator complex pro-
teins, constituting a multi-subunit complex, known to regulate the RNA polymerase II enzyme
[38]. Silencing of this gene was shown to inhibit the transcription of HIV, in part via the HIV-
Tat protein [38]. The HIV-Tat protein causes endothelial dysfunction and brings about an
inflammatory response as well as triggers loss of calcium through the RYRs on the ER [39].
These factors are part of the biological mechanisms that could contribute to atherosclerosis in
HIV. Therefore, MED30 gene-related functions may play a role in mitigating the downstream
Table 5. Admixture (LEA) results for common carotid-artery intima media thickness association with
previously significant single nucleotide polymorphisms (SNPs).
Chromosome Position SNP Gene Beta P from GWAS
Combined
8 58843783 rs1436023 LOC105375856 -0.0099 0.005
8 56847170 rs13249338 LYN -0.0099 0.005
2 98017804 rs11901495 LOC107985919 0.0096 0.005
8 55340313 rs13272749 LOC105375841 -0.0096 0.006
8 55327862 rs6987174 MRPL15, SOX17 -0.0096 0.006
8 55318559 rs7834421 MRPL15, SOX17 -0.0096 0.006
8 55369597 rs12234926 SOX17 -0.0095 0.007
5 4241397 rs7702251 IRX1, LOC101929153 0.0078 0.02
8 42045655 rs2070713 PLAT -0.0071 0.04
HIV-positive
11 17.809–18.035 rs1236207-
rs6486402
SERGEF -0.0093 0.02
5 4241397 rs7702251 IRX1, LOC101929153 0.0097 0.02
9 74974635 rs11143274 ZFAND5 -0.0091 0.02
8 58843783 rs1436023 LOC105375856 -0.0094 0.03
7 151255751 rs4726047 PRKAG2 -0.0089 0.03
1 102423144 rs4907957 OLFM3 0.0098 0.03
9 7815105 rs1360583 TMEM261, PTPRD 0.0090 0.03
19 45415640 rs445925 APOC1 0.0083 0.03
19 45814860 rs7260463 CKM 0.0081 0.04
19 35052255 rs2199639 WTIP, SCGB1B2P 0.0086 0.04
19 45740771 rs17356664 EXOC3L2 0.0080 0.04
2 98017804 rs11901495 LOC107985919 0.0082 0.04
HIV-negative
1 207524541 rs11120748 CD55 -0.0156 0.02
8 56847170 rs13249338 LYN -0.0148 0.03
2 98017804 rs11901495 LOC107985919 0.0132 0.03
9 71316454 rs1412990 LINC01506, PIP5K1B 0.01285 0.04
8 55369597 rs12234926 SOX17 -0.0141 0.04
8 55340313 rs13272749 LOC105375841 -0.0141 0.04
8 55327862 rs6987174 MRPL15, SOX17 -0.0141 0.04
8 55318559 rs7834421 MRPL15, SOX17 -0.0141 0.04
18 75938925 rs1587893 LOC10042152, LOC645321 0.0120 0.04
12 63178779 rs2641558 PPM1H -0.0126 0.04
12 63174735 rs337515 PPM1H -0.0126 0.04
https://doi.org/10.1371/journal.pone.0188725.t005
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effects of HIV in atherosclerosis and other cardiovascular complications. Spliced variants of
the gene have been observed in circulating endothelial progenitor cells and are hypothesized
to have potential diagnostic or therapeutic roles in cardiovascular disease in the future [40].
Rs2907092 was the top GWAS hit among HIV-positive women and is located in the intro-
nic region of the CTNND2 gene on chromosome 5. This gene encodes for the δ–catenin pro-
tein, a neuronal protein that is also expressed in the vascular endothelium [41]. The protein
binds cadherins to the cytoskeleton and is involved in pathways and mechanisms that modu-
late vascular remodeling. They are responsible for endothelial cell motility, angiogenesis and
wound repair regulated by inflammatory responses and are specifically observed during patho-
logic states. This gene showed a strong association with cerebral malaria in an environmental
correlation analysis (ECA), whereby the involved mechanisms such as luminal blockade by
infected cells, increased shear stress, presence of reactive oxygen species (ROS) and the ensu-
ing inflammatory response follow a pattern that is similar to atherosclerosis [42]. ECA identi-
fies genes that are enriched as a result of local environmental effects within a population that
has likely been isolated for a long period of time. As a result, the CTNND2 gene may likely
have an admixture component, which was precisely noted in our admixture results.
The most significant GWAS SNP among HIV-negative women was rs7529733 in the
regions intergenic to the FAM5C and RGS18 genes on chromosome 1. The FAM5C gene has
been associated with myocardial infarction [43] and functional studies have shown that it
increases the production of ROS, nuclear factor-kappaB (NF-κB) activity, and expression of
the intercellular and vascular cell adhesion molecules, ICAM-1 and VCAM-1 [44]. These fac-
tors induce vascular inflammation and facilitate monocyte adhesion to the endothelium. HIV
proteins such as HIV-Tat trigger this mechanism indirectly by activating the monocyte che-
moattractant protein-1 (MCP-1) resulting in migration of the monocytes and their transfor-
mation into macrophages, steps integral to the atherosclerotic process [39]. The regulator of
G-protein signaling 18 GTPase-activating protein is encoded by the RGS18 gene. This protein
is involved in the activation and inhibition of platelets through the G-α-q subunit of the het-
erotrimeric G-protein [45]. The RGS18 protein is in turn regulated by thrombin resulting in
the phosphorylation of one of its residues, and subsequent release of calcium ions to induce
platelet aggregation. A similar process is involved during platelet inhibition whereby prostacy-
clin and NO regulate RGS18 resulting in reduced intracellular calcium levels. Thus, the RGS18
effect on platelets is mediated through calcium homeostasis and therefore genetic interactions
between RGS18 and RYR3 gene are possible, and may play a substantial role in atherosclerosis
as platelets are involved in its inflammatory response.
The top admixture mapping results for the combined, and stratified analyses among HIV-
positive women revealed genes that are pseudogenes, and which have not yet been evaluated
for associations with human complex diseases or traits. The second top hit involves the gala-
nin-like peptide encoded by the GALP gene on chromosome 19. It is a neuropeptide of the
galanin family and has been shown to play a role in homeostatic processes of the central ner-
vous system (CNS) [46]. These include but are not limited to hormonal regulation of food
intake with the potential to develop obesity and other weight gain related complications like
diabetes. Additionally, a splice variant of the peptide called alarin was observed to have vasoac-
tive properties and induced vasoconstriction and decrease in water retention in the epidermis.
Diabetes and obesity are risk factors for atherosclerosis and CVD, and vascular perturbations
in the microvasculature are known to induce downstream effects that play a role in the athero-
sclerotic process. The TRPM6 gene located on chromosome 9 was associated with cCIMT
among HIV-positive women. This gene encodes for the transient receptor potential melastatin
6 channel which acts as both a channel and an enzyme involved in the regulation of magne-
sium (Mg2+) in the body [47]. TRPM6 and TRPM7 were both found in the vascular smooth
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muscle cells and were shown to regulate hypertension via Mg2+ homeostasis. Reduced Mg2+
increases blood pressure by increasing the reactivity and contractility of the blood vessels
and is also responsible for endothelial dysfunction, inflammation and vascular remodeling.
All the above-mentioned mechanisms are involved in the ongoing process of atherosclerosis
and subsequent CVD and therefore TRPM6 may play a part in the development of CVD.
Among HIV-negative women, the top LEA region was on chromosome 10 and located in the
intergenic region of the SEC23IP and PPAPDC1A genes. The rs1571099 SNP in PPAPDC1A
was significantly associated with interventricular septal wall thickness among African Ameri-
cans in a recent GWAS using the Candidate Gene Association Resource (CARe) Study [48].
This gene is involved in pathways related to innate immunity, phagocytosis and triacylglycerol
synthesis [49]. Therefore, this gene may also play a role in atherosclerosis, albeit an indirect
one.
Replication revealed associations with some of the cCIMT-SNPs found significant in earlier
studies. Previously, we had reported the association of two SNPs in RYR3 –rs2229116 and
rs7177922 that had achieved genome-wide significance among HIV-positive men of European
ancestry [20], with successful replication of rs2229116 in another group of HIV-positive White
men [21]. However, we did not find any association with these SNPs in the current analysis.
Instead, we found another SNP–rs2572204 in RYR3 that was associated with cCIMT among
HIV-positive women of WIHS. We reported the same association among Black HIV-positive
women in our previous candidate-gene study on RYR3 in WIHS. The different SNP associa-
tions within this gene may either be because of the differences in race or sex between the two
studies. WIHS women are also noted to have different heart disease risk because of differences
in their immunosuppression or duration of ART as compared to HIV-positive men [50, 51].
Nonetheless, RYR3 appears to play a role in HIV-related atherosclerosis risk based on some of
the possible gene (or protein) interactions found significant in this study. The admixture asso-
ciation of the SERGEF gene in the HIV-positive women provides further support for the role
of this gene in atherosclerosis. However, the direction of association was opposite to that
observed in the HIV-negative population in our previous study. The gene encodes a guanine
nucleotide exchange factor that may play a role in atherosclerosis through immune or inflam-
matory mechanisms via guanosine-triphosphatases and serotonin [25]. We speculate that
lower cCIMT associated with SERGEF in the HIV-positive women may be a result of immuno-
suppression because of ART or HIV itself or in conjunction with the gene as it appears to
mediate atherosclerosis through immune-related mechanisms.
Population stratification is an issue that needs to be addressed during GWAS to avoid spu-
rious associations, more so in admixed populations. Literature on genetic association studies
among admixed populations has persistently examined different approaches to account for
population structure. An initial and basic approach was genomic control [52] which was
improved upon by Price et al. [27] who suggested controlling for principal components. This
is currently the mostly widely used approach in GWAS and other genetic association studies
among admixed populations. However, recent studies argue that adjusting for global ancestry
is not sufficient and does not account for ancestry at the marker level for each individual SNP
which is commonly referred to as local ancestry [28]. To this effect, joint testing of admixture
and association was proposed and demonstrated an increase in statistical power and accuracy
of the results compared to existing methods [30, 31]. In the current study, we compared the
performance of two different methods based on level of ancestry adjustment; the methods are
described in the supplementary methods section (S1 File) and the results are presented in S3
Table. The comparison shows that the power is highest for the QSUM test that adjusts for
both local and global ancestries using the MIXSCORE program. Pasaniuc et al. reported that
the QATT test performed better for quantitative traits but also noted that the QSUM test
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might perform better given a set of conditions where high signals of admixture associations
were observed [30]. The BMIX test as proposed by Shriner et al. performs even better than the
QSUM test with a power of ~72% to detect phenotype-genotype associations in the overall
analysis [31]. Both results support the hypothesis that joint testing with adjustment for both
local and global ancestries is more powerful than the current association tests in use. There-
fore, we performed a secondary analysis using BMIX and present our results in the supplemen-
tal S4 Table. Of note, the top SNPs in Table 2 showed similar significance after adjustment for
local ancestry using BMIX (if available). Since BMIX uses the local ancestry information avail-
able through admixture mapping, as such the two analyses are not independent of each other.
In our study, we did not conduct the primary GWAS analyses using the BMIX method as we
could only estimate local ancestry in 473,732 SNPs, and so adjustment with local ancestry
would have dramatically reduced the number of informative SNPs available for GWAS. Never-
theless, this approach of adjustment for both local and global ancestry has not been extensively
explored and needs further validation to ensure broader application in future genetic studies
among admixed populations and also tease shared traits across ancestries [53].
The advantage of using the WIHS cohort is that a higher proportion of women in the
cohort were African American, especially among the HIV-positive subpopulation. It also pre-
sented us with an opportunity to evaluate the common CIMT association exclusively among
women. However, we recognize that the homogeneity of the population also reduces the gen-
eralizability of our findings. As the WIHS participants are relatively young and the incidence
of clinical CVD events is low, we could not assess the association of CVD events at the
genome-wide level. Therefore, we assessed cCIMT which is a reliable and reproducible sub-
clinical measure of atherosclerosis that has been shown to predict future CVD events. Most of
the HIV-positive women were also on combination ART including multiple antiretroviral
drugs which prevented us from evaluating the independent effect of specific ART agents on
cCIMT. Furthermore, our admixture analysis only included a subset of the SNPs that were
part of the GWAS (N = 473,732), and so we were limited in our ability to assess local ancestry
associations at the excluded SNPs. This also limited our ability to adjust for both local and
global ancestry during GWAS using the joint admixture and association testing method. We
acknowledge that the sample size was small for a genome-wide analysis, however, WIHS is
currently the largest prospective cohort of HIV-positive women in the U.S. with the cCIMT
measurements since cCIMT is not readily available, specifically among HIV-positive women.
The heterogeneity index I2 (S1 and S2 Tables) also shows that there are some consistent results
(both in direction of association and significance) but also inconsistent ones between HIV-
positive and HIV-negative groups. These results may suggest differences in underlying biologi-
cal mechanism, i.e. some of the genes or pathways maybe specific in the context of HIV (virus
itself or treatment) and others similar in both with or without infection, or they could be arti-
facts as a result of the small sample size. While we cannot conclude the reason of heterogeneity
in the two groups, the suggestive results should be examined in other populations.
In summary, we report several novel associations in relation to common CIMT among a
group of Black HIV-positive and HIV-negative women observed through genome-wide asso-
ciation and admixture analysis. The results suggest that GWAS results do not completely cap-
ture associations in regions of local ancestry and vice-a-versa among admixed populations and
both approaches may still be necessary to evaluate genotype-phenotype associations in specific
settings. These findings need to be confirmed in larger studies with local ancestry available for
a denser set of markers to allow equal comparisons across GWAS and admixture results.
Future studies may also benefit from combining data from other HIV cohorts and performing
a meta-analysis to detect novel or stronger associations.
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Methods
Ethics statement
The parent WIHS study and this sub-study conformed to the procedures for informed written
consent approved by institutional review boards (IRB) at all sponsoring organizations and to
human-experimentation guidelines set forth by the United States Department of Health and
Human Services, and finally reviewed and approved by the University of Alabama Institute
Review Board.
Study population
WIHS is a large prospective cohort of HIV-positive and risk-matched HIV-negative women
enrolled across six sites in the United States [54, 55]. The women in the study were enrolled
during the initiation phase in 1994/95 (2054 HIV-positive and 569 HIV-negative), the expan-
sion phase in 2001/02 (737 HIV-positive and 406 HIV-negative), and most recently during
2011/2012 to replace the women who had died during follow-up (270 HIV-positive and 93
HIV-negative). The study was designed to comprehensively evaluate the impact of HIV infec-
tion in U.S. women, and provide comparisons with the HIV-negative group having similar
characteristics and a high risk of acquiring the infection themselves. The women in the expan-
sion phase were included to examine the risks and benefits associated with ART. A vascular
disease sub-study was initiated in April 2004 to examine the effect of HIV and ART on subclin-
ical atherosclerosis over time, focusing specifically on inflammation, coagulation and lipid
pathways [50]. The measurements for cCIMT were obtained among 1331 HIV-positive and
534 HIV-negative women in WIHS through the vascular sub-study. In the current study, 970
Black, non-Hispanic women (682 HIV-positive and 288 HIV-negative) with complete geno-
type, phenotype and covariate information were included, after confirming the race/ethnicity
for these women using the principal components method.
Data collection. The collection and processing of data in WIHS was standardized with
centralized training of all staff before initiation of enrollment. Interviews with structured ques-
tionnaires were conducted to obtain participant-reported information on demographic, life-
style, socio-economic and clinical factors. In addition, anthropometric measures such as
weight and height; physiologic measures such as blood pressure (BP); laboratory measures
such as markers of HIV, and lipid profile were obtained using standardized protocols; and
gynecologic examinations were conducted. Follow-up every six months included collection of
interview related information and medication use [54].
CIMT images were obtained via high-resolution ultrasound by sonographers trained cen-
trally at the University of Southern California Atherosclerosis Research Unit Core Imaging
and Reading Center using a standard protocol across all study sites [56]. CIMT was measured
by the automated computerized edge-tracking method (patents 2005, 2006, 2011) [57]. The
coefficient of variation was 1.8% (intraclass correlation = 0.98; n = 113) for repeated CIMT
measurements with the initial images guiding the repeat scans. The complete ultrasound
included: 1) standardized measurements of the far-right wall of the distal common carotid
artery for CIMT, stiffness and lesions, and 2) scanning the proximal internal carotid, external
carotid and right carotid bulb at the bifurcation for lesions [50]. In the current study, we uti-
lized the common carotid artery measurements from the distal far right wall. The mean right
wall cCIMT was log base 10 transformed for normalization.
Genotyping. DNA isolation, quantification and the microplate reading were performed
using the Pure-gene DNA isolation kit (Gentra Systems, Minneapolis, MN), the PICO Green
dsDNA quantification kit (Molecular Probes, Eugene, OR) and the Perkin Elmer HTS7000
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BioAssay Reader, respectively [58]. All samples were stored at -20 oC. The genome-wide scan
was performed using the Illumina HumanOmni2.5-quad beadchip (NCBI build 37, hg19, Illu-
mina, San Diego).
Statistical analysis
Both the genome-wide and ancestry association analyses were initially conducted for all indi-
viduals followed by stratified analyses among HIV-positive and HIV-negative Black women.
Common CIMT was associated with all CVD risk factors except HDL cholesterol, and was
also not associated with ART or CD4 cell count in bivariate analysis. However, HIV related
risk factors such as ART and CD4 cell counts have been previously associated with cCIMT and
were therefore included in the final analysis.[11, 50] Analyses among all and the HIV-positive
individuals were adjusted for age, CD4 cell count, ART use, hypertension (systolic BP140
mmHg, diastolic BP90 mmHg, antihypertensive medication use or self-report), diabetes
mellitus (anti-diabetic medication use, fasting glucose126mg/dl, HgbA1C6.5%, or self-
report), current smoking, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)
cholesterol. Covariate adjustment for HIV-negative individuals was the same except for ART
use.
Quality control of genomic data and GWA analysis. Multivariable linear regression
analysis using an additive model was performed in PLINK (v1.9) with default settings [59]. In
the current study, genotype information for a total of 1,590,141 SNPs was available. Quality
control resulted in the removal of 2 SNPs because of missingness at>10%, 6,433 because of
Hardy-Weinberg equilibrium <0.001, and 459,405 because of minor allele frequency (MAF)
<5%, leaving a total of 1,124,301 SNPs to be included in the genome-wide association analysis
(S5 Table). Genetic ancestry components were evaluated with principal component (PC) anal-
ysis using 168 ancestry informative markers (AIMs) as previously described [60]. Briefly, the
number of PCs which distinguished the major racial/ethnic groups in the sample was sought
by visual inspection of scatter plots of orthogonal PCs (i.e., PC 1 versus PC2, PC2 versus
PC3). This procedure was repeated until no discernible clustering of individuals by their self-
reported race/ ethnicity was possible (data not shown) [60, 61]. Based on the scree plot (S2
Fig), GWAS analysis was adjusted for 2 principal components (PCs) in addition to the other
covariates, described above. We also tested for genomic inflation of the GWAS results by
obtaining the lambda values as well as QQ plots for both the combined as well as stratified
models. Correction for multiple testing was performed using a method proposed by Shriner
et al [31]. The method estimates the effective number of tests by fitting an autoregressive
model to the additively coded genotypes and choosing the order of the model based on the
lowest Akaike information criteria (AIC). The total number of independent tests estimated
using this method were 769,204, resulting in a threshold significance level of 6.50 x 10−8.
Local ancestry estimation. Local ancestry was estimated using the Local Ancestry in
adMixed Populations using Linkage Disequilibrium (LAMP-LD) program [62]. The program
incorporates a dense set of markers to determine ancestry at each SNP for each individual
based on haplotype sets from ancestral populations. Phased haplotype data for the reference
populations was obtained from HapMap phase II and III data from Utah residents with
North-West European ancestry (CEU) and Yorubans from Ibadan, Nigeria (YRI) for African
ancestry (HapMap phase 3, release 2). The reference haplotype data was used to determine
parameters for the Hidden Markov Model (HMM) with 15 state spaces. The local ancestry was
estimated using the HMM parameters within a 300 SNP-long window-based framework. Each
chromosome was analyzed separately and the local ancestry coded as the number of European
ancestry alleles at each SNP (i.e., 0, 1, or 2 where “0” means both chromosomal regions had
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African ancestry, “1” means the chromosomal region is admixed, one with European ancestry
and the other with African ancestry, and “2” means both chromosomal regions had European
ancestry). Before ancestry estimation, the physical coordinates for the remaining 1,124,301
SNPs were converted from hg19 to hg18 build to match the coordinates with the HapMap
phased data using the UCSC table browser [63]. As a result, 119 SNPs were lost during conver-
sion. Furthermore, 648,814 SNPs were not available in HapMap, 1,259 had ambiguous A/T or
G/C SNPs with MAF >35% and could not be resolved for strand annotation, and 63 were
duplicates; this resulted in 473,732 autosomal SNPs remaining for inclusion in the admixture
estimation and association analyses (S5 Table).
A SNP most significantly associated with the clinical events along with the block of neigh-
boring SNPs with similar number of European ancestry (“0”, “1” or “2”) were denoted as a
“LEA region”. Additionally, blocks of same ancestry LEA regions were further defined based
on whether the SNPs were in the genic or intergenic regions. A genic region included the 5’
and 3’ untranslated regions, the exons and the introns; the intergenic regions were those that
fell between two genic regions as described above. Gene nomenclatures were obtained from
the National Center for Biotechnology Information’s (NCBI) Reference Sequence database
through the web ANNOVAR program [64].
Local ancestry association with cCIMT. Association testing in relation to cCIMT was
performed using the PLINK (v1.9) software with default settings [59]. We conducted an addi-
tive linear regression analysis to evaluate the association of local ancestry coded as homozy-
gous European ancestry (11), heterozygous European/African ancestry (12) and homozygous
African ancestry (22), controlling for global European ancestry in the model. Since ancestry
estimates are highly correlated, it is necessary to calculate the total number of effective inde-
pendent tests to arrive at a threshold genome-wide significance level. We calculated the total
number of effective independent tests using the method proposed by Shriner et al for admix-
ture analysis as well [31, 65]. The total number of independent tests in our analyses was 146
resulting in a threshold significance level of 3.42 x 10−4.
Meta-analysis. Meta-analysis was performed on the results from the GWAS and admix-
ture analyses separately. The coefficients obtained from the stratified analyses of HIV-positive
and HIV-negative women were combined to obtain a pooled estimate. The analysis was con-
ducted using PLINK (v1.9) for quantitative traits with both fixed- and random-effects analysis,
including the detection of heterogeneity of the results (between HIV-positive and HIV-nega-
tive) using the heterogeneity index I2 (S1 and S2 Tables).
Evaluation of previously significant cCIMT SNPs
We identified 377 SNPs based on previous cCIMT-genetic association studies (S6 Table). Of
these, 145 SNPs were obtained from a combination of candidate gene, genome-wide (GWAS)
or meta-analysis studies [16, 19, 20, 22, 66–87], 232 SNPs from a GWAS conducted by Melton
et. al. [17]. We assessed the GWAS results and LEA regions that contained these SNPs and
report the associations for those found significant at P<0.05 in our cCIMT analysis.
Supporting information
S1 File. Supplemental methods. Comparing test performance after ancestry adjustment.
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in the association tests. QATT: quantitative Armitage’s trend test adjusting for global ances-
try, QSNP1: quantitative single nucleotide polymorphism association adjusting for local ances-
try, QADM: quantitative admixture test, QSUM: sum of QSNP1 and QADM, BMIX: joint
admixture and association test using a Bayesian approach, Score: minus log 10 p-values.
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S4 Table. Joint association and admixture (LEA) results for cCIMT in the combined, HIV-
positive, and HIV-negative models using the BMIX method.
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S5 Table. Quality control of the genome wide data from the Women’s Interagency HIV
study (WIHS). SNP: single nucleotide polymorphism, MAF: minor allele frequency.
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S6 Table. List of SNPs previously significantly associated with cCIMT in candidate gene,
genome-wide association or meta-analysis studies. Publications before the year 2004 are
represented in two reviews by Manolio TA 2004 and Pollex RL 2006. Two or more publica-
tions are referenced for some SNPs. Several SNP or gene associations were common across
studies but are only presented once in the table. Publications in bold were the only studies that
included a HIV-positive population.
(XLSX)
S1 Fig. Regional plots for the topmost hit from the genome-wide association and admix-
ture analyses. a) All women (GWAS), b) HIV-positive women (GWAS), c) HIV-negative
women (GWAS), d) All women (admixture), e) HIV-positive women (admixture), and f)
HIV-negative women (admixture). Negative log10 p-values and recombination rates are plot-
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